Vimarsana
Biggest News Aggregation in the World

Jonathan Kurtis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Kurtis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Kurtis Today - Breaking & Trending Today

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent - Vimarsana News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent

Published: May 16, 2024

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD,...

Source: globenewswire.com
Related Topics:
United StatesJake KurtisJonathan KurtisChirinjeev KathuriaWarren Alpert Medical School At Brown UniversityOcean Biomedical IncCompany Annual Report On FormLaboratory MedicineScientific Co FounderOcean BiomedicalGlobal Unmet NeedWarren Alpert Medical SchoolChief Executive OfficerRhode Island BasedAnnual ReportQuarterly ReportBiomedical Media
EXCLUSIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA) - Vimarsana News

EXCLUSIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA)

Published: October 26, 2023

Ocean Biomedical, Inc.

Source: benzinga.com
Related Topics:
New ZealandHong KongUnited StatesFalk Medical Research Trust Transformational AwardOcean Biomedical IncVirion TherapeuticsSue CurrieChief ScientistJonathan Kurtis
EXCLISIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA) - Vimarsana News

EXCLISIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA)

Published: October 26, 2023

Ocean Biomedical, Inc.

Source: benzinga.com
Related Topics:
Hong KongNew ZealandUnited StatesOcean Biomedical IncFalk Medical Research Trust Transformational AwardVirion TherapeuticsSue CurrieChief ScientistJonathan Kurtis
Analysis suggests climate change, population growth could supercharge malaria risk - Vimarsana News

Analysis suggests climate change, population growth could supercharge malaria risk

Published: October 24, 2023

Longer transmission seasons and migration of mosquitoes to new latitudes threaten to undo years of progress.

Source: umn.edu
Related Topics:
United StatesJonathan KurtisWashington PostFalk Medical Research Trust Transformational AwardSouth AmericaOcean Biomedical
AstraZeneca submits FDA application for self-administered FluMist - Vimarsana News

AstraZeneca submits FDA application for self-administered FluMist

Published: October 24, 2023

The company expects an FDA decision in the first quarter of 2024.

Source: umn.edu
Related Topics:
United StatesJonathan KurtisFalk Medical Research Trust Transformational AwardWashington PostSouth AmericaOcean Biomedical